Viewing Study NCT01316718


Ignite Creation Date: 2025-12-25 @ 5:03 AM
Ignite Modification Date: 2025-12-26 @ 4:06 AM
Study NCT ID: NCT01316718
Status: COMPLETED
Last Update Posted: 2014-01-17
First Post: 2010-09-21
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Mesalazine for the Treatment of Diarrhoea-predominant Irritable Bowel Syndrome (IBS-D)
Sponsor: University of Nottingham
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module